Utomilumab (Anti-TNFRSF9 / 4-1BB / CD137)
Utomilumab (Anti-TNFRSF9 / 4-1BB / CD137) is a fully human IgG2 monoclonal antibody targeting the T-cell costimulatory receptor 4-1BB/CD137. It can be used for the research of relapsed/refractory follicular lymphoma (FL), non-Hodgkin lymphomas (NHL). MW :142.78.
Supplier | Selleck Chemicals |
---|---|
Product # | A2620 |
Sku # | A2620-1mg |
Pricing | 1mg, $370.00 |